Cargando…
Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer
Autores principales: | Cerfolio, Robert J., Moore, William H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653107/ https://www.ncbi.nlm.nih.gov/pubmed/33209591 http://dx.doi.org/10.21037/tlcr-20-477 |
Ejemplares similares
-
Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy
por: HL, Chung, et al.
Publicado: (2022) -
CT-based radiomics of benign and malignant features in multiple cavitary pulmonary lesions
por: Pinto, Erique Guedes, et al.
Publicado: (2020) -
A CT-based radiomics nomogram for differentiation of benign and malignant small renal masses (≤4 cm)
por: Feng, Shengxing, et al.
Publicado: (2023) -
Multiphasic CT-Based Radiomics Analysis for the Differentiation of Benign and Malignant Parotid Tumors
por: Yu, Qiang, et al.
Publicado: (2022) -
Radiomics as a non-invasive adjunct to Chest CT in distinguishing benign and malignant lung nodules
por: Selvam, Minmini, et al.
Publicado: (2023)